home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

47 rows where docket_id = "FDA-2015-D-1211" and posted_year = 2015 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 3

  • Supporting & Related Material 43
  • Notice 2
  • Other 2

posted_year 1

  • 2015 · 47 ✖

agency_id 1

  • FDA 47
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2015-D-1211-0098 FDA None FDA-2015-D-1211 Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Guidance for Industry; Availability, Notice Notice of Availability 2015-12-23T05:00:00Z 2015 12 2015-12-23T05:00:00Z   2023-02-28T14:29:06Z 2015-32250 0 0 0900006481dca583
FDA-2015-D-1211-0099 FDA None FDA-2015-D-1211 Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products Guidance for Industry Other Guidance 2015-12-23T05:00:00Z 2015 12 2015-12-23T05:00:00Z   2023-02-28T14:36:21Z   0 0 0900006481dcd33a
FDA-2015-D-1211-0028 FDA None FDA-2015-D-1211 Ref. 25 Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P, Viral hepatitis and HIV co-infection re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T18:45:47Z   0 0 0900006481ae6b04
FDA-2015-D-1211-0036 FDA None FDA-2015-D-1211 Ref. 33 Custer B, Sheon N, Siedle-Khan B, Pollack L, Spencer B, Bialkowski W, D’Andrea P, Sullivan M, Glynn S, Williams A, NHLBI Recipient Epidemiology and Donor Evaluation-III (REDS-III), Noncompliance with the men who have sex with me re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T19:53:20Z   0 0 0900006481ae6c63
FDA-2015-D-1211-0040 FDA None FDA-2015-D-1211 Ref. 37 Lucky TTA, Seed CR, Waller D, Lee JF, McDonald A, Wand H, Wroth S, Shuttleworth G, Keller AJ, Pink J, Wilson DP, Understanding noncompliance with selective donor deferral criteria for high-risk behaviors in Australian blood donors re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T19:53:48Z   0 0 0900006481ae6c67
FDA-2015-D-1211-0043 FDA None FDA-2015-D-1211 Ref. 40 Weller S, Davis-Beaty K, Condom effectiveness in reducing heterosexual HIV transmission re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T19:54:05Z   0 0 0900006481ae6c6a
FDA-2015-D-1211-0033 FDA None FDA-2015-D-1211 Ref. 30 FDA workshop on Quarantine Release Errors in Blood Establishments, September 2011 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T19:53:01Z   0 0 0900006481ae6d98
FDA-2015-D-1211-0034 FDA None FDA-2015-D-1211 Ref. 31 HHS Advisory Committee on Blood and Tissue Safety and Availability, Results from the Uniform Donor History Questionnaire, December 2013 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T19:53:09Z   0 0 0900006481ae6d99
FDA-2015-D-1211-0019 FDA None FDA-2015-D-1211 Ref. 16 Klamroth R, Gröner A, Simon TL, Pathogen inactivation and removal methods for plasma-derived clotting factor concentrates re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:17:56Z   0 0 0900006481ae6322
FDA-2015-D-1211-0006 FDA None FDA-2015-D-1211 Ref. 3 Stramer SL, Dodd RY, Transfusion-transmitted emerging infectious disease: 30 years of challenges and progress re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:16:22Z   0 0 0900006481ae668d
FDA-2015-D-1211-0009 FDA None FDA-2015-D-1211 Ref. 6 Centers for Disease Control and Prevention, Epidemiologic Notes and Reports Possible Transfusion-Associated Acquired Immune Deficiency Syndrome re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:16:51Z   0 0 0900006481ae6317
FDA-2015-D-1211-0041 FDA None FDA-2015-D-1211 Ref. 38 Mark KP, Janssen E, Milhausen RR, Infidelity in heterosexual couples: demographic, interpersonal, and personality-related predictors of extradyadic sex, Arch Sex Behav 2011 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T19:53:53Z   0 0 0900006481ae6c68
FDA-2015-D-1211-0027 FDA None FDA-2015-D-1211 Ref. 24 United Kingdom Scientific, SaBTO Advisory Committee on the Safety of Blood, Tissues and Organs, Donor Selection Criteria Review, April 2011 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T18:45:41Z   0 0 0900006481ae6aa3
FDA-2015-D-1211-0029 FDA None FDA-2015-D-1211 Ref. 26 Purcell DW, Johnson CH, Lansky A, Prejean J, Stein R, Denning P, Gaul Z, Weinstock H, Su J, Crepaz N, Estimating the population size of men who have sex with men in the United States to obtain HIV and syphilis rates re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T18:45:52Z   0 0 0900006481ae6b05
FDA-2015-D-1211-0038 FDA None FDA-2015-D-1211 Ref. 35 Offergeld R, et al, Sexual risk behavior and donor deferral in Europe, Vox Sanguinis 2014 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T19:53:34Z   0 0 0900006481ae6c65
FDA-2015-D-1211-0044 FDA None FDA-2015-D-1211 Ref. 41 Smith DK, Herbst JH, Zhang X, Rose CE, Condom effectiveness for HIV prevention by consistency of use among men who have sex with men in the united states, J Acquir Immune Defic Syndr 2015 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T19:54:10Z   0 0 0900006481ae6c6b
FDA-2015-D-1211-0022 FDA None FDA-2015-D-1211 Ref. 19 FDA Blood Products Advisory Committee Meeting, September 14, 2000 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T18:45:12Z   0 0 0900006481ae6a9e
FDA-2015-D-1211-0026 FDA None FDA-2015-D-1211 Ref. 23 Kucirka LM1, Sarathy H, Govindan P, Wolf JH, Ellison TA, Hart LJ, Montgomery RA, Ros RL, Segev DL, Risk of window period HIV infection in high infectious risk donors re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T18:45:36Z   0 0 0900006481ae6aa2
FDA-2015-D-1211-0011 FDA None FDA-2015-D-1211 Ref. 8 Van de Perre P, Clumeck N, Carael M, Nzabihimana E, Robert-Guroff M, De Mol P, Freyens P, Butzler JP, Gallo RC, Kanyamupira JB, Female prostitutes: a risk group for infection with human T-cell lymphotropic virus type III re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:17:05Z   0 0 0900006481ae6319
FDA-2015-D-1211-0012 FDA None FDA-2015-D-1211 Ref. 9 FDA Memorandum Recommendations to decrease the Risk of Tramitting AIDS fro Blood donors re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:17:11Z   0 0 0900006481ae631a
FDA-2015-D-1211-0025 FDA None FDA-2015-D-1211 Ref. 22 Federal Register Notice, “Request for Information (RFI) on Design of a Pilot Operational Study To Assess Alternative Blood Donor Deferral Criteria for Men Who Have Had Sex With Other Men re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T18:45:30Z   0 0 0900006481ae6aa1
FDA-2015-D-1211-0030 FDA None FDA-2015-D-1211 Ref. 27 CDC, HIV Surveillance Report, 2012; vol 24. Published November 2014 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T18:45:59Z   0 0 0900006481ae6b06
FDA-2015-D-1211-0010 FDA None FDA-2015-D-1211 Ref. 7 Ginzburg HM, Intravenous drug users and the acquired immune deficiency syndrome re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:16:58Z   0 0 0900006481ae6318
FDA-2015-D-1211-0003 FDA None FDA-2015-D-1211 REFERENCE LIST re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:16:00Z   0 0 0900006481ae6688
FDA-2015-D-1211-0035 FDA None FDA-2015-D-1211 Ref. 32 Custer B, Kessler D, Vahidnia F, Leparc G, Krysztof DE, Shaz B, Kamel H, Glynn S, Dodd RY, Stramer SL; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), Risk factors for retrovirus and hepatitis virus re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T19:53:14Z   0 0 0900006481ae6d9a
FDA-2015-D-1211-0015 FDA None FDA-2015-D-1211 Ref. 12 Perkins HA, Busch MP, Transfusion-associated infections: 50 years of relentless challenges and remarkable progress re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:17:33Z   0 0 0900006481ae631d
FDA-2015-D-1211-0031 FDA None FDA-2015-D-1211 Ref. 28 CDC, Estimated HIV incidence in the United States, 2007–2010. HIV Surveillance Supplemental Report 2012; 17(No. 4). Published December 2012 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T18:46:05Z   0 0 0900006481ae6b07
FDA-2015-D-1211-0037 FDA None FDA-2015-D-1211 Ref. 34 Benjamin RJ, et al, Deferral of males who had sex with other males, Vox Sanguinis 2011 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T19:53:27Z   0 0 0900006481ae6c64
FDA-2015-D-1211-0042 FDA None FDA-2015-D-1211 Ref. 39 Stone E, Heagerty P, Vittinghoff E, Douglas JM Jr, Koblin BA, Mayer KH, Celum CL, Gross M, Woody GE, Marmor M, Seage GR III, Buchbinder SP, Correlates of condom failure in a sexually active cohort of men who have sex with men re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T19:53:59Z   0 0 0900006481ae6c69
FDA-2015-D-1211-0020 FDA None FDA-2015-D-1211 Ref. 17 FDA Blood Products Advisory Committee Meeting, December 11-12, 1997 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T18:45:00Z   0 0 0900006481ae6a9c
FDA-2015-D-1211-0017 FDA None FDA-2015-D-1211 Ref. 14 Ward JW, Grindon AJ, Feorino PM, Schable C, Parvin M, Allen JR, Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:17:44Z   0 0 0900006481ae631f
FDA-2015-D-1211-0014 FDA None FDA-2015-D-1211 Ref. 11 Centers for Disease Control and Prevention, Current Trends Prevention of Acquired Immune Deficiency Syndrome (AIDS): Report of Inter-Agency Recommendations re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:17:26Z   0 0 0900006481ae631c
FDA-2015-D-1211-0023 FDA None FDA-2015-D-1211 Ref. 20 FDA Workshop on Behavior-Based Donor Deferral in the NAT Era, 2006 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T18:45:18Z   0 0 0900006481ae6a9f
FDA-2015-D-1211-0045 FDA None FDA-2015-D-1211 Ref. 42 FDA Blood Products Advisory Committee Meeting, December 2014 transcript re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T19:54:17Z   0 0 0900006481ae6c6c
FDA-2015-D-1211-0021 FDA None FDA-2015-D-1211 Ref. 18 FDA Workshop on Donor Suitability, 1998 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T18:45:05Z   0 0 0900006481ae6a9d
FDA-2015-D-1211-0024 FDA None FDA-2015-D-1211 Ref. 21 HHS Advisory Committee for blood safety and availability mtg, 2010 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T18:45:25Z   0 0 0900006481ae6aa0
FDA-2015-D-1211-0039 FDA None FDA-2015-D-1211 Ref. 36 Seed CR, Kiely P, Law M, Keller AJ, No evidence of a significantly increased risk of transfusion-transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12-month deferral for men who have had sex with men re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T19:53:41Z   0 0 0900006481ae6c66
FDA-2015-D-1211-0016 FDA None FDA-2015-D-1211 Ref. 13 Centers for Disease Control and Prevention, Update: Revised Public Health Service Definition of Persons Who Should Refrain from Donating Blood and Plasma – United States re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:17:38Z   0 0 0900006481ae631e
FDA-2015-D-1211-0032 FDA None FDA-2015-D-1211 Ref. 29 AABB on Quarantine Release Errors, White Paper 2013 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T18:46:10Z   0 0 0900006481ae6b08
FDA-2015-D-1211-0013 FDA None FDA-2015-D-1211 Ref. 10 Leveton LB, Sox Jr HC, Stoto MA, eds, HIV and the blood supply: an analysis of crisis decisionmaking, Institute of Medicine, National Academy Press, Washington DC 1995 re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:17:17Z   0 0 0900006481ae631b
FDA-2015-D-1211-0018 FDA None FDA-2015-D-1211 Ref. 15 Zou S, Stramer SL, Dodd RY, Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:17:50Z   0 0 0900006481ae6320
FDA-2015-D-1211-0004 FDA None FDA-2015-D-1211 Reference. 1 FDA Memorandum to all Registered Blood Establishments re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:16:07Z   0 0 0900006481ae668a
FDA-2015-D-1211-0005 FDA None FDA-2015-D-1211 Ref. 2 Epstein JS, Jaffe HW, Alter HJ, Klein HG, Blood system changes since recognition of transfusion-associated AIDS re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:16:15Z   0 0 0900006481ae668b
FDA-2015-D-1211-0007 FDA None FDA-2015-D-1211 Ref. 4 Dubin C, Francis D, Closing the circle: a thirty-year retrospective on the AIDS/blood epidemic re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:16:28Z   0 0 0900006481ae668e
FDA-2015-D-1211-0008 FDA None FDA-2015-D-1211 Ref. 5 Centers for Disease Control and Prevention, Epidemiologic Notes and Reports Pneumocystis carinii Pneumonia among Persons with Hemophilia A re Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Supporting & Related Material Background Material 2015-05-18T04:00:00Z 2015 5     2015-05-18T16:16:36Z   0 0 0900006481ae668f
FDA-2015-D-1211-0001 FDA None FDA-2015-D-1211 Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry; Availability Notice Notice of Availability 2015-05-15T04:00:00Z 2015 5 2015-05-15T04:00:00Z 2015-07-15T03:59:59Z 2023-04-27T01:00:42Z 2015-11690 0 0 0900006481ae2a95
FDA-2015-D-1211-0002 FDA None FDA-2015-D-1211 Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Draft Guidance for Industry Other Guidance 2015-05-15T04:00:00Z 2015 5 2015-05-15T04:00:00Z   2023-02-28T14:36:50Z   0 0 0900006481ae3a52

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 1598.388ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API